Demographic and clinical characteristics of 363 patients with IE | |
---|---|
Age (years), mean ± SD | 65 ± 15 |
Gender (women), n (%) | 123 (34) |
BMI, mean ± SD | 25.0 ± 4.1 |
Renal failure, n (%) | 96 (26) |
 Mild n (%) | 41 (43) |
 Moderate n (%) | 34 (35) |
 Severe n (%) | 14 (15) |
 On dialysis n (%) | 7 (7) |
Arterial hypertension, n (%) | 212 (59) |
Previous malignancies, n (%) | 79 (22) |
Drug abuse, n (%) | 43 (12) |
Diabetes, n (%) | 68 (18) |
Dyslipidemia, n (%) | 109 (30) |
Pacemaker, n (%) | 41 (11) |
Oral anticoagulant therapy, n (%) | 91 (25) |
Clinical and echocardiographic characteristics of 363 episodes of IE | |
Prosthetic valve, n (%) | 132 (36) |
First episode of IE, n (%) | 330 (90) |
Systemic embolism, n (%) | 141 (39) |
Cerebral embolism, n (%) | 67 (47) |
Perivalvular extension, n (%) | 84 (23) |
Severe valvular dysfunction, n (%) | 172 (47) |
Vegetation length (mm), mean ± SD | 9.1 ± 7.6 |
Ejection Fraction (%), mean ± SD | 56.7 ± 10.0 |
TAPSE (mm), mean ± SD | 20.8 ± 5.6 |
Euroscore II | 12.4 ± 16.5 |